Litigation Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Annora Pharma Private Limited (D. Del. 2020)
✉ Email this page to a colleague
Boehringer Ingelheim Pharmaceuticals Inc. v. Annora Pharma Private Limited (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-02-25 |
Court | District Court, D. Delaware | Date Terminated | 2020-11-10 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Patents | 10,258,637 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Boehringer Ingelheim Pharmaceuticals Inc. v. Annora Pharma Private Limited
Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Annora Pharma Private Limited (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-02-25 | 1 | Complaint | the expiration of United States Patent No. 10,258,637 (the “’637 patent”). Case 1:20-cv-00277-UNA Document…and legally issued United States Patent No. 10,258,637 (“the ’637 patent”) entitled “Pharmaceutical Composition… U.S. PATENT NO. 10,258,637 30. On April 16, 2019, the USPTO…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United… correct copy of the ’637 patent is attached as Exhibit 1. The ’637 patent is assigned to BII. BIC and | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |